Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Apr 16, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how well a new pain management technique works for patients undergoing liver surgery, known as hepatic resection. Researchers want to find out if adding a specific type of nerve block called an erector spinae plane (ESP) catheter to the usual pain relief methods, which include a medication called intrathecal morphine, can help reduce pain after surgery more effectively than just using the regular pain relief methods alone.

To participate in this study, patients must be 18 or older, scheduled for liver surgery, and able to give consent. However, those who are pregnant, in prison, have severe liver disease, or are taking high doses of opioids for a long time may not be eligible. Participants can expect to receive either the ESP catheter or standard care during their surgery, and doctors will monitor their pain levels afterward to see which method works better. This study is currently recruiting participants and aims to improve how patients manage pain after liver surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • undergoing hepatic resection
• • Admitting service requests APS consult
• • \>18 years old and able to provide consent
• Exclusion criteria:
• • pregnancy
• • incarceration
• • inability to communicate with the investigators and hospital staff
• • severe hepatic disease
• • chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
• • BMI \> 40 kg/m2
• • allergy to study medications (lidocaine, ropivacaine)